Clinical Trials Logo

Osteoarthrosis Deformans clinical trials

View clinical trials related to Osteoarthrosis Deformans.

Filter by:
  • None
  • Page 1

NCT ID: NCT02967874 Completed - Osteoarthritis Clinical Trials

Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment

Start date: March 2016
Phase: Phase 1/Phase 2
Study type: Interventional

Adipose-derived stromal vascular fraction cells (SVFs) include regenerative cell populations (hematopoietic cells, pericytes, endothelial cells and progenitors, stromal/stem cells) and thus are potentially important as new therapeutic tools for the repair and regeneration of acute and chronically damaged tissues. The general objective of this study is to evaluate safety and clinical efficacy of a single intra-articular injection of freshly isolated auto-SVFs for the treatment of patients with knee osteoarthritis (OA). This study uses autologous adipose-derived SVFs, as therapeutic agent and intra-articular administration, as a mode of delivery. Expected clinical effects: a treatment reduces pain, increases function and reduces stiffness in the knees of osteoarthritic subjects.

NCT ID: NCT02341079 Withdrawn - Osteoarthritis Clinical Trials

Intraoperative Liposomal Bupivacaine Injection in Primary Total Knee Arthroplasty

Start date: March 2015
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to evaluate the efficacy of local infiltration of liposomal bupivacaine versus use of an indwelling femoral peripheral nerve block in controlling early postoperative pain in primary total knee arthroplasty. The investigators hope to demonstrate equivalency of treatment modalities to provide an alternative to the commonly used treatment of femoral nerve blockade.